The Jehovah’s Witnesses have revised their stance on the medical use of donated blood, allowing members to receive products derived from blood while maintaining a ban on whole-blood transfusions. This policy change, announced on September 18, 2026, marks the second revision this year to one of the organization’s most distinctive teachings. According to Geoffrey W. Jackson, a member of the Governing Body, individuals can now receive medical treatments involving the four main components of whole blood: plasma, platelets, and red and white blood cells.
The new policy permits Jehovah’s Witnesses to make personal decisions about using blood components in medical and surgical care. Members are allowed to receive treatments that involve the use of these components, which can be derived from donated blood. However, the organization continues to prohibit members from receiving transfusions of whole blood or donating blood for that purpose. This decision reflects a nuanced approach to the use of blood in medical treatment, allowing for individual conscience while upholding core teachings.
In addition to allowing the use of blood-derived products, the revised policy also permits members to decide whether to donate blood for use in medical treatments for others. This aspect of the policy change enables Jehovah’s Witnesses to contribute to the medical treatment of others while still adhering to their core principles. The Governing Body has emphasized the importance of individual conscience in making these decisions, allowing members to make choices that align with their personal beliefs.
This policy revision is not the first change to the Jehovah’s Witnesses’ stance on blood transfusions this year. In March 2026, the Governing Body announced a revised policy authorizing members to have their blood stored for their own future medical treatment, but not for others. These changes reflect a gradual evolution in the organization’s approach to the use of blood in medical treatment, balancing the need for medical care with adherence to core principles.
The Jehovah’s Witnesses’ prohibition on whole-blood transfusions has long been a distinctive and controversial aspect of their teachings. The organization’s stance has been shaped by their interpretation of biblical principles, which has guided their approach to medical treatment. While the revised policy allows for greater flexibility in the use of blood-derived products, the organization remains committed to its core principles regarding the use of whole blood.
The announcement of the revised policy has implications for Jehovah’s Witnesses worldwide, who will be expected to make informed decisions about their medical care. The organization has emphasized the importance of individual conscience in making these decisions, allowing members to make choices that align with their personal beliefs. As the Jehovah’s Witnesses continue to navigate the complexities of medical treatment, their approach to the use of blood will remain a key aspect of their teachings.
The revised policy on blood transfusions and blood-derived products reflects the Jehovah’s Witnesses’ ongoing efforts to balance their core principles with the need for medical care. As the organization continues to evolve its approach to medical treatment, it will be important to monitor the implications of this policy change for members and the broader medical community.
Key points
- Jehovah’s Witnesses can now receive products derived from blood, including plasma, platelets, and red and white blood cells.
- The organization maintains a ban on whole-blood transfusions and donating blood for that purpose.
- Members are allowed to decide as a matter of individual conscience whether to donate blood for use in medical treatments for others.
